Elevai Labs, Inc.(ELAB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ELAB Elevai Labs, Inc.

Post-Market Trading 05-21 16:04:17 EDT

0.6899

+0.0149

+2.21%

盘后0.6890

-0.0009-0.13%

16:00 EDT

High0.7000	Low0.6631	Vol113.68K
Open0.6990	D1 Closing0.6750	Amplitude5.47%
Mkt Cap13.03M	Tradable Cap1.03M	Total Shares18.89M
T/O76.62K	T/O Rate7.58%	Tradable Shares1.50M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ELAB","market":"US","secType":"STK","nameCN":"Elevai Labs, Inc.","latestPrice":0.6899,"timestamp":1716321591652,"preClose":0.675,"halted":0,"volume":113680,"hourTrading":{"tag":"盘后","latestPrice":0.689,"preClose":0.6899,"latestTime":"16:00 EDT","volume":32,"amount":22.048,"timestamp":1716321601208},"delay":0,"floatShares":1500000,"shares":18892115,"eps":-0.365021,"marketStatus":"Post-Market Trading","change":0.0149,"latestTime":"05-21 16:04:17 EDT","open":0.699,"high":0.7,"low":0.6631,"amount":76621.3726768,"amplitude":0.054667,"askPrice":0.6999,"askSize":1935,"bidPrice":0.6627,"bidSize":700,"shortable":3,"etf":0,"ttmEps":-0.365021,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1716336000000},"marketStatusCode":4,"adr":0,"listingDate":1700542800000,"exchange":"NASDAQ","adjPreClose":0.675,"preHourTrading":{"tag":"盘前","latestPrice":0.6627,"preClose":0.675,"latestTime":"08:45 EDT","volume":12010,"amount":7961.032069499999,"timestamp":1716295555928},"postHourTrading":{"tag":"盘后","latestPrice":0.689,"preClose":0.6899,"latestTime":"16:00 EDT","volume":32,"amount":22.048,"timestamp":1716321601208},"volumeRatio":1.204671},"requestUrl":"/m/hq/s/ELAB/tweets","defaultTab":"tweets","newsList":[{"id":"2436889102","title":"IPO roundup: KDLY, BOW, and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2436889102","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2436889102?lang=en_us&edition=fundamental","pubTime":"2024-05-20 23:11","pubTimestamp":1716217874,"startTime":"0","endTime":"0","summary":"Headlines making waves in the IPO sector include the recent cancellation of Games Global's (GGL) debut on public markets. The company, a casino game supplier for platforms like DraftKings (DKNG) and F","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/812466544/image_812466544.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/812466544/image_812466544.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4108211-ipo-roundup-kdly-bow-and-more","is_publish_highlight":false,"gpt_icon":0},{"id":"2436166617","title":"Wall Street Breakfast: The Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2436166617","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2436166617?lang=en_us&edition=fundamental","pubTime":"2024-05-19 18:35","pubTimestamp":1716114940,"startTime":"0","endTime":"0","summary":"Listen on the go!","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1002175840/image_1002175840.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1002175840/image_1002175840.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4694370-wall-street-breakfast-week-ahead","is_publish_highlight":false,"gpt_icon":0},{"id":"2436105600","title":"Elevai Labs reports Q1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2436105600","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2436105600?lang=en_us&edition=fundamental","pubTime":"2024-05-17 00:48","pubTimestamp":1715878120,"startTime":"0","endTime":"0","summary":"Elevai Labs press release  (NASDAQ:ELAB): Q1 comprehensive loss of $1.4M\nRevenue of $0.61M (+335.7% Y/Y).","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4107618-elevai-labs-reports-q1-results","is_publish_highlight":false,"gpt_icon":0},{"id":"2435366026","title":"Elevai Labs Q1 EPS $(0.081) Up From $(0.111) YoY, Sales $614.56K Up From $142.82K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2435366026","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2435366026?lang=en_us&edition=fundamental","pubTime":"2024-05-16 05:11","pubTimestamp":1715807515,"startTime":"0","endTime":"0","summary":"Elevai Labs (NASDAQ:ELAB) reported quarterly losses of $(0.08) per share. This is a 27.03 percent increase over losses of $(0.11) per share from the same period last year. The company reported $614.56 thousand in sales","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38859768/elevai-labs-q1-eps-0-081-up-from-0-111-yoy-sales-614-56k-up-from-142-82k-yoy","is_publish_highlight":false,"gpt_icon":0},{"id":"2435660806","title":"Elevai Labs Q1 2024 Revneue $614.563K Up From $142.820K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2435660806","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2435660806?lang=en_us&edition=fundamental","pubTime":"2024-05-16 05:00","pubTimestamp":1715806805,"startTime":"0","endTime":"0","summary":"Elevai Labs Q1 2024 Revneue $614.563K Up From $142.820K YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38859314/elevai-labs-q1-2024-revneue-614-563k-up-from-142-820k-yoy","is_publish_highlight":false,"gpt_icon":0},{"id":"2435622086","title":"Elevai Labs Inc. Reports First Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2435622086","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2435622086?lang=en_us&edition=fundamental","pubTime":"2024-05-16 04:30","pubTimestamp":1715805000,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., May 15, 2024  -- Elevai Labs Inc.  , a pioneering force in medical aesthetics, today reported financial results for the first quarter ended March 31, 2024.Elevai Labs CEO, Jordan R. Plews, PhD stated, \"This quarter, Elevai Labs has demonstrated remarkable year-over-year revenue growth while significantly improving our gross margin, reflecting our commitment to optimizing production and stringent cost management. We remain focused on sustainable growth while enhancing our operational efficiencies and continuing to invest in innovation. These results underscore our adaptability and strategic foresight in meeting marketdemands.\". Revenueincreased to $614,563 for the three months ended March 31, 2024, compared to $142,820 for the three months ended March 31, 2023 and $698,591 for the three months ended December 31, 2023, a 330.3% increase year-over-year and 12.0% decrease quarter-over-quarter.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZhGHM1I49mnk_yJEQm_jxQ--~B/aD0zMjI7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/aea9a8377e8f26159cee3a0715b5b4e7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZhGHM1I49mnk_yJEQm_jxQ--~B/aD0zMjI7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/aea9a8377e8f26159cee3a0715b5b4e7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elevai-labs-inc-reports-first-203000848.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432704957","title":"ELEVAI Labs Expands Portfolio and Restructures Subsidiaries","url":"https://stock-news.laohu8.com/highlight/detail?id=2432704957","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2432704957?lang=en_us&edition=fundamental","pubTime":"2024-05-03 05:42","pubTimestamp":1714686175,"startTime":"0","endTime":"0","summary":"The latest update is out from ELEVAI Labs Inc. (ELAB). Elevai Labs, Inc. has secured an exclusive license from MOA Life Plus Co., Ltd. to commercia...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/elevai-labs-expands-portfolio-and-restructures-subsidiaries?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/elevai-labs-expands-portfolio-and-restructures-subsidiaries?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2432160399","title":"Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2432160399","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2432160399?lang=en_us&edition=fundamental","pubTime":"2024-05-02 20:30","pubTimestamp":1714653000,"startTime":"0","endTime":"0","summary":"Preclinical results of EL-22 from a 2022 study demonstrated physiological , physical , and functional  improvements in the dystrophic features of mdx mice, a mouse model of Duchenne muscular dystrophy 1.Elevai believes that EL-22 has the potential to treat obesity in combination with popular weight loss therapeutics, including GLP-1 receptor agonists, by preserving muscle mass while decreasing fat mass.Elevai plans to submit an Investigational New Drug  application in 2025 that utilizes the licensed asset EL-22, previously called BLS-M221.EL-22 showed a statistically significant increase in anti-myostatin IgG antibody concentration, where myostatin is a key negative regulator of muscle growth.EL-22 administered to mdx mice, a mouse model of Duchenne muscular dystrophy, had improved physical activity and gross motor function, as demonstrated by a longer duration during rotarod tests.Based on the highlighted preclinical data, Elevai believes that EL-22 has the potential to treat obesity ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZhGHM1I49mnk_yJEQm_jxQ--~B/aD0zMjI7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/aea9a8377e8f26159cee3a0715b5b4e7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZhGHM1I49mnk_yJEQm_jxQ--~B/aD0zMjI7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/aea9a8377e8f26159cee3a0715b5b4e7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elevai-biosciences-highlights-preclinical-data-123000692.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432346266","title":"Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare","url":"https://stock-news.laohu8.com/highlight/detail?id=2432346266","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2432346266?lang=en_us&edition=fundamental","pubTime":"2024-05-01 20:00","pubTimestamp":1714564800,"startTime":"0","endTime":"0","summary":"Elevai Labs established two subsidiaries: Elevai Biosciences, Inc., and Elevai Skincare, Inc.Elevai Biosciences will focus on acquiring and developing biopharmaceutical technologies with initial focus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/01/2873591/0/en/Elevai-Labs-Expands-with-Launch-of-Elevai-Biosciences-and-Elevai-Skincare-Subsidiaries-Advancing-the-Future-of-Aesthetic-Medicines-and-Exosome-Skincare.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432571266","title":"Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2432571266","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2432571266?lang=en_us&edition=fundamental","pubTime":"2024-05-01 13:00","pubTimestamp":1714539600,"startTime":"0","endTime":"0","summary":"Agreement adds two drug candidates to product pipeline consisting of (i) “EL-22”, a clinical stage engineered probiotic expressing myostatin, and (ii) “EL-32”, a preclinical engineered probiotic expre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/01/2873316/0/en/Elevai-Labs-Acquires-Exclusive-License-to-Two-Myostatin-Muscle-Loss-Prevention-Assets-with-Plan-to-Develop-in-Combination-with-GLP-1-Obesity-Treatments.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431866115","title":"Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments","url":"https://stock-news.laohu8.com/highlight/detail?id=2431866115","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2431866115?lang=en_us&edition=fundamental","pubTime":"2024-04-29 13:45","pubTimestamp":1714369500,"startTime":"0","endTime":"0","summary":"Fiveinternational distribution agreements signed to dateCumulative contracted minimum purchase requirements of $4.9M in the firstfive yearsUp to fiveadditional international distribution agreements in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/29/2871350/0/en/Elevai-Labs-Highlights-Global-Distribution-Partnership-Overview-Contracts-May-Secure-4-9M-Top-Line-Revenue-Commitments.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2423497844","title":"Elevai Labs reports Q4 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2423497844","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2423497844?lang=en_us&edition=fundamental","pubTime":"2024-03-30 00:51","pubTimestamp":1711731078,"startTime":"0","endTime":"0","summary":"Elevai Labs press release  : Q4 total comprehensive loss was $708,508. Revenueincreased to $698,591 for the three months ended December 31, 2023, compared to $138,898 for the three months ended December 31, 2022. More on Elevai Labs  ELEVAI LABS reports preliminary total net revenue for 2023 of over $1.635M ELAB, KIND and RLX among pre-market losers Financial information for Elevai Labs","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4085324-elevai-labs-reports-q4-results","is_publish_highlight":false,"gpt_icon":0},{"id":"2423863149","title":"15 Best Beauty Stocks To Invest In","url":"https://stock-news.laohu8.com/highlight/detail?id=2423863149","media":"Insider Monkey","top":-1,"share":"https://ttm.financial/m/news/2423863149?lang=en_us&edition=fundamental","pubTime":"2024-03-29 01:38","pubTimestamp":1711647537,"startTime":"0","endTime":"0","summary":"In this piece, we will take a look at the 15 best beauty stocks to invest in. If you want to skip our overview of the global beauty industry, then you can take a look at the 5 Best Beauty Stocks To Invest In.The global beauty industry sits right at the heart of the multi billion dollar media and entertainment sector. Newscasters, television show hosts, models, actors, and even politicians have to groom themselves in order to address hundreds of thousands of people daily. Therefore, the beauty industry, made up of global giants, sits right at the top of the stock market when it comes to valuation.Apart from NYSE:PERF, there are several other beauty technology stocks that are at the edge of the industry and exposed to innovation at the same time. A couple of these are Oddity Tech Ltd. , Elevai Labs, Inc. , and Cu","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B_7FuXD9xIxMM9BODv630A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ce6daa13d54523253158b888a5e9028b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B_7FuXD9xIxMM9BODv630A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ce6daa13d54523253158b888a5e9028b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/15-best-beauty-stocks-invest-173857175.html","is_publish_highlight":false,"gpt_icon":1},{"id":"2420473443","title":"Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2420473443","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2420473443?lang=en_us&edition=fundamental","pubTime":"2024-03-18 12:30","pubTimestamp":1710736200,"startTime":"0","endTime":"0","summary":"ELEVAI Physician-Dispensed Skincare Now Available Direct to Consumers. Elevai e-commerce portal webview of the shopping cart and physician finder tool. Elevai e-commerce portal mobile view of the shopping cart and physician finder tool","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/03/18/2847796/0/en/Elevai-Labs-Launches-E-commerce-Portal-to-Support-Rapid-Growth-as-Stem-Cell-Exosome-Disruptor-in-the-19-7-Billion-Global-Physician-Dispensed-Cosmeceutical-Market.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2417432177","title":"ELEVAI Labs Inc.: Stock Price Woes and Board Reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2417432177","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2417432177?lang=en_us&edition=fundamental","pubTime":"2024-03-08 05:27","pubTimestamp":1709846832,"startTime":"0","endTime":"0","summary":"The latest update is out from ELEVAI Labs Inc. (ELAB). Elevai Labs Inc. faces a challenge as it has fallen below Nasdaq’s minimum bid price require...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/elevai-labs-inc-stock-price-woes-and-board-reshuffle?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/elevai-labs-inc-stock-price-woes-and-board-reshuffle?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2405432464","title":"ELEVAI LABS announces issuance of patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2405432464","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2405432464?lang=en_us&edition=fundamental","pubTime":"2024-01-24 21:45","pubTimestamp":1706103928,"startTime":"0","endTime":"0","summary":"ELEVAI Labs  said the United States Patent & Trademark Office issued a patent, which covers the primary formulation for ELEVAI’s exosome-based skin care products.\"We are pleased the USPTO has issued this critical patent, which is the first step towards building ELEVAI’s patent moat in the aesthetics market,\" saidco-founder and CEO, Jordan Plews.More on Elevai Labs, Inc.  ELEVAI LABS reports preliminary total net revenue for 2023 of over $1.635M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4057838-elevai-labs-announces-issuance-of-patent","is_publish_highlight":false,"gpt_icon":0},{"id":"2405443827","title":"ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office","url":"https://stock-news.laohu8.com/highlight/detail?id=2405443827","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2405443827?lang=en_us&edition=fundamental","pubTime":"2024-01-24 13:30","pubTimestamp":1706074200,"startTime":"0","endTime":"0","summary":"Utility Patent Covers the formulation for ELEVAI’s flagship exosome-based skin care productsNEWPORT BEACH, Calif., Jan.  24, 2024  (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ: ELAB) a medical aesth","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/01/24/2815309/0/en/ELEVAI-Labs-Inc-Announces-Issuance-of-Patent-from-U-S-Patent-Trademark-Office.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.elevailabs.com","stockEarnings":[{"period":"1week","weight":0.038},{"period":"1month","weight":0.1801},{"period":"3month","weight":-0.0878},{"period":"6month","weight":-0.8055},{"period":"1year","weight":-0.8313},{"period":"ytd","weight":-0.6308}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0705},{"period":"3month","weight":0.067},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.1152}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.","exchange":"NASDAQ","name":"Elevai Labs, Inc.","nameEN":"Elevai Labs, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Elevai Labs, Inc.(ELAB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Elevai Labs, Inc.(ELAB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Elevai Labs, Inc.,ELAB,Elevai Labs, Inc.股票,Elevai Labs, Inc.股票老虎,Elevai Labs, Inc.股票老虎国际,Elevai Labs, Inc.行情,Elevai Labs, Inc.股票行情,Elevai Labs, Inc.股价,Elevai Labs, Inc.股市,Elevai Labs, Inc.股票价格,Elevai Labs, Inc.股票交易,Elevai Labs, Inc.股票购买,Elevai Labs, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Elevai Labs, Inc.(ELAB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Elevai Labs, Inc.(ELAB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction